Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer. Cella L, Finocchiaro A, Slusarczyk A, Krajewski W, et al. Future Oncol 2026 Apr 27:1-9. doi: 10.1080/14796694.2026.2661768.

Read + Share

Amedeo Smart

Independent Medical Education

Cella L, Finocchiaro A, Slusarczyk A, Krajewski W, et al. Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer. Future Oncol 2026 Apr 27:1-9. doi: 10.1080/14796694.2026.2661768.
PMID: 42041162